AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ESTRADIOL VALERATE

5 registrations across 3 African markets— 4 active

Markets with ESTRADIOL VALERATE

🇬🇭Ghana
2 registrations
2 active
🇳🇬Nigeria
2 registrations
2 active
🇨🇮Côte d'Ivoire
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
Oestrafert 2 mg
Tablet
🇳🇬NigeriaMark Pharmaceutical LimitedactiveNov 2029
Progynova 2 mg Tablet**
Tablet
🇳🇬NigeriaBayer Nigeria LimitedactiveMay 2029
PROGYNOVA​ TABLETS 2mg🇬🇭Ghana—activeJan 2027
PROGYNOVA​ TABLETS 2mg🇬🇭Ghana—activeJan 2027
CLIMENE COMPRIME BOITE DE 21🇨🇮Côte d'IvoireBAYER HEALTHCARE SASexpiredJun 2019

ESTRADIOL VALERATE in Africa — Regulatory Overview

ESTRADIOL VALERATE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.